Analysts Recommended this Stock: OvaScience, Inc. (OVAS)

Bank of America Merrill Lynch

OvaScience, Inc. (OVAS) belonging to the Healthcare sector has surged 2.22% and closed its last trading session at $1.38.

The company reported its EPS on 9/29/2017. Currently, the stock has a 1 Year Price Target of $8.

The consensus recommendation, according to Zacks Investment research, is 2.33. The scale runs from 1 to 5 with 1 recommending Strong Buy and 5 recommending a Strong Sell.

The Stock had a 2.33 Consensus Analyst Recommendation 30 Days Ago, whereas 60 days ago and 90 days ago the analyst recommendations were 2.33 and 2.33 respectively.

OvaScience, Inc. on 9/29/2017 reported its EPS as $-0.49 with the analysts projecting the EPS of the stock as $-0.58. The company beat the analyst EPS Estimate with the difference of $0.09. This shows a surprise factor of 0.155%.

Many analysts have provided their estimated foresights on OvaScience, Inc. Earnings, with 4 analysts believing the company would generate an Average Estimate of $-0.28.

Whereas they predicted High and Low Earnings Estimate as $-0.23 and $-0.32 respectively. While in the same Quarter Previous year, the Actual EPS was $-0.49.

Analysts are also projecting an Average Revenue Estimate for OvaScience, Inc. as $140000 in the Current Quarter. This estimate is provided by 4 analysts.

For the Current Quarter, the growth estimate for OvaScience, Inc. is 42.9%, while for the Next Quarter the stock growth estimate is 33.3%.

 

OvaScience, Inc. (OVAS) has the market capitalization of $48.89 Million. The company rocked its 52-Week High of $3.25 and touched its 52-Week Low of $1.25.

The stock has Return on Assets (ROA) of -64.3 percent. Return on Equity (ROE) stands at -73.1% and Return on Investment (ROI) of -75.1 percent.

The stock is currently showing YTD performance of -9.8 Percent. The company has Beta Value of 3.5 and ATR value of 0.08. The Weekly and Monthly Volatility stands at 5.04% and 5.59%.

 

You may missed